MARKET

QTNT

QTNT

Quotient
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.730
-0.150
-3.87%
After Hours: 3.730 0 0.00% 16:00 04/03 EDT
OPEN
3.900
PREV CLOSE
3.880
HIGH
3.950
LOW
3.640
VOLUME
311.80K
TURNOVER
--
52 WEEK HIGH
11.30
52 WEEK LOW
2.395
MARKET CAP
299.56M
P/E (TTM)
-2.4130
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average QTNT stock price target is 13.50 with a high estimate of 14.00 and a low estimate of 13.00.

EPS

QTNT News

More
  • Chairman of the Board Heino von Prondzynski Just Bought Shares In Quotient Limited (NASDAQ:QTNT)
  • Simply Wall St. · 03/15 14:47
  • Quotient Limited to Host Investor Information Conference Call and Live Webcast
  • GlobeNewswire · 03/13 20:30
  • Quotient Limited Reports Concordance Data from Extended Serological Disease Screening Benchmark Study
  • GlobeNewswire · 02/24 21:05
  • Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray
  • GlobeNewswire · 02/14 13:04

Industry

Medical Equipment, Supplies & Distribution
-0.92%
Healthcare Equipment & Supplies
-1.17%

Hot Stocks

Symbol
Price
%Change

About QTNT

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
More

Webull offers kinds of Quotient Ltd stock information, including NASDAQ:QTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QTNT stock news, and many more online research tools to help you make informed decisions.